Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Recombinant NDV-GM-CSF: a lead project from MedImmune's NDV oncolytic platform

Nov. 10, 2014

Pim kinase inhibitor found to sensitize SCLC cells to BH3 mimetic

Nov. 10, 2014

Biomarkers may identify patients with dengue with warning signs

Nov. 10, 2014

Beloranib as promising treatment of obesity and food-related behavior in Prader-Willi Syndrome

Nov. 7, 2014

Effectiveness of a bumped kinase inhibitor against toxoplasmosis

Nov. 7, 2014

New pan-RAF inhibitors effective in melanomas resistant to BRAF or BRAF/MEK inhibitors

Nov. 7, 2014

Novel cystine derivatives inhibit stone formation in vivo

Nov. 7, 2014

New clinical data presented on nivolumab in the treatment of renal cell carcinoma

Nov. 6, 2014

CYD tetravalent dengue vaccine found efficacious in phase III studies in children in Latin America

Nov. 6, 2014

Phase III data presented on new levonorgestrel intrauterine contraceptive system

Nov. 6, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...